Market Tracker

05/27 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

10.00
Delayed Data
As of May 27
 +0.11 / +1.11%
Today’s Change
6.96
Today|||52-Week Range
25.25
-42.30%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close9.89
Today’s open9.90
Day’s range9.79 - 10.05
Volume638,768
Average volume (3 months)1,785,059
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-308.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book29.80

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.06+0.47%
FPRXFive Prime Therapeut...0.000.00%
MCRBSeres Therapeutics I...+0.18+0.61%
RDUSRadius Health Inc+1.40+4.16%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts